Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7126 AL 7140

Targeting the glymphatic system: Aβ accumulation and phototherapy strategies across different stages of Alzheimer's disease

Zhao D, Wang J, Zhu Y, Zhang H, Ni C, Zhao Z, Dai J, He R, Liu G, Gan C, Zhang S, Tong Z.

Transl Neurodegener. 2025 Sep 24;14(1):49. doi: 10.1186/s40035-025-00510-8.

Synbiotics in Alzheimer's disease: mechanisms, clinical evidence, and therapeutic prospects

Lin Y, Weng R, Pan H, Hou Y, Sun Y, Wen J.

J Transl Med. 2025 Sep 24;23(1):1009. doi: 10.1186/s12967-025-07064-3.

Treatment for Alzheimer's disease

Fox NC, Belder C, Ballard C, Kales HC, Mummery C, Caramelli P, Ciccarelli O, Frederiksen KS, Gomez-Isla T, Ismail Z, Paquet C, Petersen RC, Perneczky R, Robinson L, Sayin O, Frisoni GB.

Lancet. 2025 Sep 27;406(10510):1408-1423. doi: 10.1016/S0140-6736(25)01329-7. Epub 2025 Sep 22.

Alzheimer's disease outlook: controversies and future directions

Frisoni GB, Aho E, Brayne C, Ciccarelli O, Dubois B, Fox NC, Frederiksen KS, Gabay C, Garibotto V, Hofmarcher T, Jack CR Jr, Kivipelto M, Petersen RC, Ribaldi F, Rowe CC, Walsh S, Zetterberg H, Hansson O.

Lancet. 2025 Sep 27;406(10510):1424-1442. doi: 10.1016/S0140-6736(25)01389-3. Epub 2025 Sep 22.

Targeting the awry Aβ pathway in Alzheimer's disease: hype and hurdles

Al-Kuraishy HM, Sulaiman GM, Al-Gareeb AI, Mohammed HA, Albuhadily AK, Abomughaid MM.

Inflammopharmacology. 2025 Oct;33(10):5945-5961. doi: 10.1007/s10787-025-01983-9. Epub 2025 Sep 27.

Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers

Schreiber CP, Kovacik A, Bishop J, Helman J.

Drugs Aging. 2025 Dec;42(12):1103-1111. doi: 10.1007/s40266-025-01253-x. Epub 2025 Oct 3.

TDP-43 in Alzheimer's disease: Pathophysiology and therapeutic strategies

Zhou X, Lin X, He Y, Huang N, Luo Y.

Pharmacol Res. 2025 Nov;221:107977. doi: 10.1016/j.phrs.2025.107977. Epub 2025 Oct 4.

Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer's disease

Fan X, Wang H, Ping J, Li M, Gu J, Qian W.

Biochem Pharmacol. 2025 Dec;242(Pt 3):117401. doi: 10.1016/j.bcp.2025.117401. Epub 2025 Oct 3.

lncRNA EPB41L4A-AS1: A promising therapeutic target for aging and age-related diseases

Li M, Li T, Zhang X, Li K, Wang Z.

Mech Ageing Dev. 2025 Dec;228:112118. doi: 10.1016/j.mad.2025.112118. Epub 2025 Oct 9.

Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer's disease

Amniouel S, Suh J, Zheng W, Zhang Q.

Transl Neurodegener. 2025 Oct 13;14(1):51. doi: 10.1186/s40035-025-00513-5.

Anti-Amyloid Therapies for Alzheimer's Disease: Progress, Pitfalls, and the Path Ahead

Papaliagkas V.

Int J Mol Sci. 2025 Sep 29;26(19):9529. doi: 10.3390/ijms26199529.

[Significance of Amyloid Plaque Removal in Alzheimer's Disease Treatment: Development of Amyloid β-Targeting Antibody Drugs Based on the Amyloid Cascade Hypothesis]

Kowa H, Sato S, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Oct;77(10):1129-1136. doi: 10.11477/mf.188160960770101129.

Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer's disease

Sahoo S, Pattanaik S, Kar DM, Prusty SK, Sahu PK.

Gene. 2025 Nov 20;972:149827. doi: 10.1016/j.gene.2025.149827. Epub 2025 Oct 15.

The impact of nutritional and exercise interventions on Alzheimer's disease pathophysiology via modulation of the microbiota-gut-brain-axis

Noble N, Gold A, Zhu J.

Nutr Neurosci. 2026 Mar;29(3):371-388. doi: 10.1080/1028415X.2025.2565706. Epub 2025 Oct 21.

Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversies

Wang XY, Jia YJ, Zhang J, Chen JF, Wang YJ, Chen X.

J Alzheimers Dis. 2025 Dec;108(4):1441-1451. doi: 10.1177/13872877251388664. Epub 2025 Oct 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias